Shares News

Xiaomi is a Hong Kong-listed technology company whose Q1 2026 results showed EV segment losses, smartphone margin pressure and a planned HK$20bn buyback. Explore third-party 1810 price targets and technical analysis. Past performance is not a reliable indicator of future results.

Thyssenkrupp’s 16 June supervisory board meeting will decide the future of its €11.4bn Materials Services division, with options including a spin-off, IPO, or sale. Explore third-party TKA price targets and technical analysis. Past performance is not a reliable indicator of future results.

HENSOLDT is a German defence electronics company. In June 2026, it raised 2026 free cash flow guidance after Q1 order intake more than doubled. Explore third-party HAG price targets and technical analysis. Past performance is not a reliable indicator of future results.

Allianz reported record Q1 2026 operating profit of €4.52bn, alongside continued inflows at PIMCO and an ongoing €2.5bn share buyback. Explore third-party ALV price targets and technical analysis. Past performance is not a reliable indicator of future results.

BioNTech is a German biotechnology company listed on Nasdaq, with recent BNTX sentiment shaped by ASCO oncology data and lower Q1 revenue. Explore third-party BNTX price targets and technical analysis. Past performance is not a reliable indicator of future results.

BYD is a Chinese EV and battery maker. In May, overseas sales rose 80.4% year-on-year to 160,644 units, while domestic sales remained under pressure. Explore third-party 1211 price targets and technical analysis. Past performance is not a reliable indicator of future results.

Siemens Energy is a German energy technology group that reported record Q2 FY2026 orders of €17.70bn and raised its full-year guidance in May 2026. Explore third-party ENR price targets and technical analysis. Past performance is not a reliable indicator of future results.

Palantir Technologies is a US software company whose Q1 2026 results included $1.63bn in revenue, adjusted EPS of $0.33 and raised full-year guidance. Explore third-party PLTR price targets and technical analysis. Past performance is not a reliable indicator of future results.

Novo Nordisk is a Danish pharmaceutical company whose 2026 outlook reflects Q1 results, Wegovy sales, oral Wegovy uptake and GLP-1 competition. Explore third-party NVO price targets and technical analysis. Past performance is not a reliable indicator of future results.

BASF reported Q1 2026 sales of €16.0bn and EBITDA before special items of €2.356bn, while its €1.5bn buyback continued through June 2026. Explore third-party BAS price targets and technical analysis. Past performance is not a reliable indicator of future results.